Dong, P.; Ma, L.; Liu, L.; Zhao, G.; Zhang, S.; Dong, L.; Xue, R.; Chen, S.
CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis. Int. J. Mol. Sci. 2016, 17, 320.
https://doi.org/10.3390/ijms17030320
AMA Style
Dong P, Ma L, Liu L, Zhao G, Zhang S, Dong L, Xue R, Chen S.
CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis. International Journal of Molecular Sciences. 2016; 17(3):320.
https://doi.org/10.3390/ijms17030320
Chicago/Turabian Style
Dong, Pingping, Lijie Ma, Longzi Liu, Guangxi Zhao, Si Zhang, Ling Dong, Ruyi Xue, and She Chen.
2016. "CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis" International Journal of Molecular Sciences 17, no. 3: 320.
https://doi.org/10.3390/ijms17030320
APA Style
Dong, P., Ma, L., Liu, L., Zhao, G., Zhang, S., Dong, L., Xue, R., & Chen, S.
(2016). CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis. International Journal of Molecular Sciences, 17(3), 320.
https://doi.org/10.3390/ijms17030320